Furthermore, the regulation of KMO expression could be crucial for the treatment of GBM, since in GBM cell cultures, KMO expression is upregulated after incubation with temozolomide but downregulated after incubation with the cyclin dependent kinase inhibitor, dinaciclib [51]. This evidence concerns the gene KMO and glioblastoma.